121 related articles for article (PubMed ID: 11721395)
1. [Inhibition of hematopoiesis by sera from patients with myelodysplastic syndromes].
Ding R; Liu H; Xu R
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):515-7. PubMed ID: 11721395
[TBL] [Abstract][Full Text] [Related]
2. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.
Boula A; Voulgarelis M; Giannouli S; Katrinakis G; Psyllaki M; Pontikoglou C; Markidou F; Eliopoulos GD; Papadaki HA
Clin Cancer Res; 2006 May; 12(10):3099-108. PubMed ID: 16707608
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
5. [Induction of apoptosis of CD34+ cells by serum from two patients with severe aplastic anemia].
Liu H; Wu F; Jiang S
Zhonghua Xue Ye Xue Za Zhi; 1998 Oct; 19(10):514-7. PubMed ID: 11189494
[TBL] [Abstract][Full Text] [Related]
6. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
7. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
Wu L; Li X; Chang C; Ying S; He Q; Pu Q
Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
[TBL] [Abstract][Full Text] [Related]
9. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
Glaser M
Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
[TBL] [Abstract][Full Text] [Related]
10. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
11. Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes.
Katsoulidis E; Li Y; Yoon P; Sassano A; Altman J; Kannan-Thulasiraman P; Balasubramanian L; Parmar S; Varga J; Tallman MS; Verma A; Platanias LC
Cancer Res; 2005 Oct; 65(19):9029-37. PubMed ID: 16204077
[TBL] [Abstract][Full Text] [Related]
12. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
[TBL] [Abstract][Full Text] [Related]
14. [The effects of sera of acute promyelocytic leukemia patients and culture supernates of NB4 cells on normal granulo-macrophage hematopoiesis].
Zhou R; Sun G; Wu W
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):343-6. PubMed ID: 11721428
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis.
Briggs RC; Shults KE; Flye LA; McClintock-Treep SA; Jagasia MH; Goodman SA; Boulos FI; Jacobberger JW; Stelzer GT; Head DR
Cancer Res; 2006 May; 66(9):4645-51. PubMed ID: 16651415
[TBL] [Abstract][Full Text] [Related]
16. Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes.
Stasi R; Amadori S
Br J Haematol; 2002 Feb; 116(2):334-7. PubMed ID: 11841434
[TBL] [Abstract][Full Text] [Related]
17. Enriched levels of erythropoietin in human umbilical cord blood stimulate hematopoietic progenitor cells.
Lawlor GF; Tauchi T; Ohyashiki K; Matsumiya T
J Biochem Mol Biol Biophys; 2002 Feb; 6(1):65-70. PubMed ID: 12186785
[TBL] [Abstract][Full Text] [Related]
18. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.
Ohmori M; Ohmori S; Ueda Y; Yoshida Y; Okuma M
Int J Cell Cloning; 1991 Sep; 9(5):521-30. PubMed ID: 1955740
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis in MDS].
Anzai N; Kawabata H; Hishita T; Ueda Y; Yoshida Y
Rinsho Ketsueki; 1996 Jul; 37(7):536-41. PubMed ID: 8779768
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]